Regeneron Pharmaceuticals (REGN)

Revenue

$16.90B

TTM · Period ending: · USD

REGN logo

REGN Revenue

Latest reported$16.90B
REGN TTM Revenue ($5.00M → $16.90B)
High-resolution chart · PNG

REGN revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Revenue — Trailing twelve months (TTM) (USD)
Period endingRevenue (USD)
16,896,200,000
15,534,700,000
14,919,600,000
14,342,900,000
14,247,800,000
14,214,200,000
14,085,700,000
14,202,000,000
13,847,100,000
13,489,100,000
13,100,100,000
13,117,200,000
13,097,300,000
12,670,800,000
12,369,900,000
12,172,900,000
13,710,200,000
14,226,800,000
16,508,100,000
16,071,700,000
13,542,900,000
12,384,100,000
9,197,600,000
8,497,100,000
7,937,700,000
7,387,400,000
7,013,200,000
6,557,600,000
6,621,900,000
6,541,696,000
6,571,918,000
6,710,803,000
6,365,450,000
6,202,627,000
6,064,721,000
5,872,227,000
5,516,607,000
5,236,056,000
4,978,569,000
4,860,427,000
4,731,677,000
4,648,977,000
4,434,965,000
4,103,728,000
3,807,980,000
3,396,346,000
3,063,429,000
2,819,557,000
2,627,640,000
2,498,879,000
2,290,821,000
2,104,745,000
1,908,935,000
1,739,595,000
1,586,352,000
1,378,477,000
1,086,852,000
761,998,000
565,409,000
445,824,000
456,522,000
459,668,000
467,744,000
459,074,000
422,199,000
433,675,000
407,821,000
379,268,000
338,305,000
286,434,000
257,055,000
238,457,000
247,350,000
204,077,000
165,619,000
125,024,000
70,640,000
63,953,000
61,016,000
63,447,000
70,525,000
71,095,000
68,203,000
66,193,000
95,859,000
116,184,000
128,236,000
174,017,000
148,199,000
129,072,000
111,186,000
59,332,000
42,972,000
32,146,000
27,183,000
21,988,000
21,477,000
20,391,000
20,601,000
24,745,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.